Health Care & Life Sciences » Pharmaceuticals | Flexion Therapeutics Inc.

Flexion Therapeutics Inc.

Flexion Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.48
Market Cap
$422.48 M
Shares Outstanding
37.99 M
Public Float
31.47 M

Profile

Address
10 Mall Road
Burlington Massachusetts 01803
United States
Employees -
Website http://www.flexiontherapeutics.com
Updated 07/08/2019
Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand.

Financials

View All
Created with Highcharts 5.0.14Flexion Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.18 18618 18627 31327 31346 31546 31571 89471 894137 481137 481169 659169 659201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Flexion Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000000035535522 52422 52420132014201520162017201805k10k15k20k25k

Michael D. Clayman
President, Chief Executive Officer & Director
Patrick J. Mahaffy
Chairman